Masonic Cancer Center, University of Minnesota clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-20
What changed in the last 30 days
4 trials changed in the last 30 days: 0 stopped, 3 with notable changes, 1 with a minor change only.
- Notable: Auto Stem Cell Transplant for Lymphoma Patients Primary completion pushed from Sep 30, 2026 to Sep 30, 2027
- Minor: Intravenous Laronidase Pharmacokinetics Before and After Hematopoietic Cell Transplantation · Mucopolysaccharidosis Type IH Study completion pushed from Oct 1, 2026 to Oct 1, 2027
- Notable: MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis Primary completion pushed from Jan 5, 2026 to Jan 5, 2030
- Notable: Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue · High-Risk Neuroblastoma Primary completion pushed from Oct 1, 2026 to Oct 1, 2027
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-02 | NCT07910019 Evaluating Prostate Cancer Patient Natural Killer Cell Function Across Racial Background… | Recruiting |
Active trials by phase
| Early Phase 1 | 1 | |
| Phase 1 | 9 | |
| Phase 1/2 | 2 | |
| Phase 2 | 16 |
Not charted: 20 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials, top 10 of 27
Leukemia (11) · Acute Myeloid Leukemia (AML) (8) · Acute Lymphoblastic Leukemia (ALL) (7) · Myelodysplastic Syndromes (MDS) (7) · Non-Hodgkin Lymphoma (7) · Follicular Lymphoma (4) · Chronic Myeloid Leukemia (CML) (3) · Hodgkin Lymphoma (3) · Mantle Cell Lymphoma (3) · Ovarian Cancer (3)
Get alerts when Masonic Cancer Center, University of Minnesota's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.